DOSING, TREATMENT PATTERNS, UACR CHANGES, AND SAFETY WITH FINERENONE TREATMENT: AN INTERIM ANALYSIS OF THE ASIA-PACIFIC COHORT OF FINE-REAL

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/fbde3a2bfae84193e3ebb2bba732a748.pdf
DOSING, TREATMENT PATTERNS, UACR CHANGES, AND SAFETY WITH FINERENONE TREATMENT: AN INTERIM ANALYSIS OF THE ASIA-PACIFIC COHORT OF FINE-REAL

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Nan Hee
Kim
Nan Hee Kim nhkendo@gmail.com Korea University College of Medicine Division of Endocrinology and Metabolism, Department of Internal Medicine Seoul Korea (Republic of) *
Lixin Guo glx1218@163.com Chinese Academy of Medical Sciences Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine Beijing China -
Kevin M. Pantalone PANTALK@ccf.org Cleveland Clinic . Cleveland, OH United States -
Christoph Wanner Wanner_C@ukw.de University Hospital Würzburg . Würzburg Germany -
David C. Wheeler d.wheeler@ucl.ac.uk University College London . London United Kingdom -
Nihar R. Desai nihar.desai@yale.edu Yale School of Medicine . New Haven, CT United States -
Ricardo Correa-Rotter correarotter@gmail.com Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran . Ciudad de Mexico Mexico -
Susanne B. Nicholas sunicholas@mednet.ucla.edu David Geffen School of Medicine University of California Los Angeles, CA United States -
Sonia Ares Gómez sonia.gomez.ext@bayer.com Syneos Health . Madrid Spain -
Andrea Horvat-Broecker andrea.horvat-broecker@bayer.com Bayer AG . Wuppertal Germany -
Marcel Schulze marcel.schulze1@bayer.com Bayer AG . Berlin Germany -
Martin Merz martin.merz@bayer.com Bayer AG . Berlin Germany -
Sankar D. Navaneethan Sankar.Navaneethan@bcm.edu Baylor College of Medicine . Houston, TX United States -
-
-